Literature DB >> 33948663

Rheumatic mitral regurgitation: is repair justified by the long-term results?

Cinzia Trumello1, Ilaria Giambuzzi2,3, Giorgia Bonalumi2, Marta Bargagna1, Moreno Naliato2, Stefania Ruggeri1, Daniele Fileccia2,3, Alessandro Castiglioni1, Ottavio Alfieri1, Francesco Alamanni2,3, Michele De Bonis1.   

Abstract

OBJECTIVES: The best treatment for rheumatic mitral regurgitation is still under debate. Our goal was to assess the long-term results of mitral repair for rheumatic mitral regurgitation performed in 2 referral centres for mitral repair.
METHODS: Patients who underwent mitral valve repair between 1999 and 2009 were selected. Preoperative and postoperative data were prospectively entered into a dedicated database and retrospectively reviewed. Kaplan-Meier estimates were used to analyse long-term survival. Competing risk analysis was performed by calculating the cumulative incidence function for time to recurrence of mitral regurgitation ≥3+, mitral regurgitation ≥2+, mitral reoperation and the combined end point of repair failure (mitral regurgitation ≥ 3+ and/or mean gradient ≥ 10 mmHg and/or mitral valve REDO) with death as a competing risk.
RESULTS: A total of 72 patients were included. Mitral calcifications were present in 25 patients (34.7%). Most of the patients (65/72, 90.3%) underwent annuloplasty, and mixes of reparative techniques were used in 21 patients (29.2%). In-hospital mortality was 2.8%. Mean follow-up was 11.6 ± 5.16 (max 19.1 years), 98.6% completed. Survival at 14 years was 70 ± 6.27%. At 14 years, the cumulative incidence function of repair failure was 36.7 ± 6.52%. The presence of severe mitral annulus calcification was an independent predictor of repair failure.
CONCLUSIONS: Mitral repair for rheumatic mitral regurgitation is characterized by a high rate of failure in the long term (14 years), particularly in patients with severe annular calcifications. These results call for a very selective approach when considering a repair strategy in this setting, especially in case of unfavourable anatomical conditions.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Mitral Reparair; Mitral Replacement; Rheumatic Mitral Regurgitation

Mesh:

Year:  2021        PMID: 33948663      PMCID: PMC8691521          DOI: 10.1093/icvts/ivab091

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  15 in total

1.  Rheumatic heart disease: the tip of the iceberg.

Authors:  Karen Sliwa; Peter Zilla
Journal:  Circulation       Date:  2012-05-24       Impact factor: 29.690

2.  Mitral valve repair and replacement for rheumatic disease.

Authors:  T M Yau; Y A El-Ghoneimi; S Armstrong; J Ivanov; T E David
Journal:  J Thorac Cardiovasc Surg       Date:  2000-01       Impact factor: 5.209

3.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Volkmar Falk; Helmut Baumgartner; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur J Cardiothorac Surg       Date:  2017-10-01       Impact factor: 4.191

4.  Rheumatic mitral valve repair: 22-year clinical results.

Authors:  Charles A Yankah; Henryk Siniawski; Christine Detschades; Julia Stein; Roland Hetzer
Journal:  J Heart Valve Dis       Date:  2011-05

5.  Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era.

Authors:  Rakesh M Suri; Hartzell V Schaff; Joseph A Dearani; Thoralf M Sundt; Richard C Daly; Charles J Mullany; Maurice Enriquez-Sarano; Thomas A Orszulak
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

6.  Re-repair after previous mitral valve reconstruction: handle with care!

Authors:  Cinzia Trumello; Ilaria Giambuzzi; Benedetto Del Forno; Marta Bargagna; Andrea Blasio; Stefania Ruggeri; Roberta Meneghin; Davide Schiavi; Simona Nascimbene; Alessandro Castiglioni; Ottavio Alfieri; Michele De Bonis
Journal:  Interact Cardiovasc Thorac Surg       Date:  2020-07-01

7.  Is rheumatic aetiology a predictor of poor outcome in the current era of mitral valve repair? Contemporary long-term results of mitral valve repair in rheumatic heart disease.

Authors:  Mohd Azhari Yakub; Jeswant Dillon; Paneer S Krishna Moorthy; Kiew Kong Pau; Mohd Nazeri Nordin
Journal:  Eur J Cardiothorac Surg       Date:  2013-02-27       Impact factor: 4.191

8.  A complexity scoring system for degenerative mitral valve repair.

Authors:  Anelechi C Anyanwu; Shinobu Itagaki; Joanna Chikwe; Ahmed El-Eshmawi; David H Adams
Journal:  J Thorac Cardiovasc Surg       Date:  2016-01-22       Impact factor: 5.209

9.  Extending the scope of mitral valve repair in rheumatic disease.

Authors:  Bachar El Oumeiri; Munir Boodhwani; David Glineur; Laurent De Kerchove; Alain Poncelet; Parla Astarci; Agnes Pasquet; Jean-Louis Vanoverschelde; Robert Verhelst; Jean Rubay; Philipe Noirhomme; Gébrine El Khoury
Journal:  Ann Thorac Surg       Date:  2009-06       Impact factor: 4.330

10.  Mitral valve repair is superior to valve replacement for the early preservation of cardiac function: relation of ventricular geometry to function.

Authors:  J F Ren; S Aksut; G W Lighty; G J Vigilante; J D Sink; B L Segal; W C Hargrove
Journal:  Am Heart J       Date:  1996-05       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.